Follow us on social media!
Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/

Have you ever wondered who's behind the MS News Today social media platforms? Ally Macgregor chats with Ed Tobias (@themswire) and Arelis Castillo (@msconstruedfashion) about their roles as the social media coordinators for MS News Today, their diagnosis stories, and how they use writing and fashion to connect with others in the MS community.You can watch this conversation again, here. Also, don't forget to check us out and follow us on social media!#InstagramLive here: https://www.instagram.com/tv/CVOsGokJ3fN/

Follow us on social media!
Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/

Have you ever wondered who's behind the MS News Today social media platforms? Ally Macgregor chats with two of the folks behind MS News Today’s online community, Rochelle (@thisisrochelle) and Desiree Lama (@thedeslama), about their diagnosis journeys, managing work with MS, and more. Hear about their MS journeys and how they like to spend their time when they're not online. ⠀You can watch this conversation again, here. Also, don't forget to check us out and follow us on social media!#InstagramLive here: https://www.instagram.com/tv/CVOsGokJ3fN/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how patients who had six weeks of vibration training have showed better cognitive function and life quality, and lesser disability in a small study; and reads “As My Disease Progresses, I Choose to Grow”, a column by Jennifer Powell.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how National MS Society investments support 29 training fellowships, early career awards, and research projects aligned with its Pathways to Cures Roadmap; and reads “He’s Fallen in the Water!”, a column by John Connor.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about a how a Phase 3 trial analysis showed ADS-5102 significantly increased walking speed in 21% MS patients with difficulties; further work stopped.Also, Price Wooldridge reads “It’s Flu Vaccine Time Again, So Here’s What You Need to Know”, a column by Ed Tobias.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Jenn Powell speaks with Director of Forums for SMA News Today, Kevin Schaefer Director of Forums for SMA News Today, Kevin Schaefer started at BioNews in 2017 as a columnist for SMA News Today, sharing his experiences as an adult with SMA Type 2. He eventually transitioned to a full-time role, helping build the company’s multimedia and forums divisions. Join Jenn and Kevin as they discuss commonalities between their diseases, how SMA and MS have changed their lives, and how having a sense of purpose has been pivotal in their ability to thrive with their diseases. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/

Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday

For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about experiencing serious infections during adolescence and how this can be tied to an increased risk of developing multiple sclerosis later in life.Price also reads “When Restless Legs Syndrome Won’t Leave You Alone”, a column by Jennifer Powell.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about neurofilament light chain blood levels and cortical thinning on MRIs in recently diagnosed RRMS patients linked with poorer cognitive tests; and reads the column by John Connor, Fall Down, Get Up Again, “Down and Out in London Town!”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about BioNews Clinical, which aims to help clinical trials, essential to therapy, enroll people with rare and chronic disorders who want to participate.Price also reads “3 Things I Discovered at My 50th College Reunion”, a column by Ed Tobias.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about Belong.Life's, a new i-Belong app that allows health professionals, advocacy groups, pharmas and others to build and manage patient communities. He also reads “Next Time, Ask Me Why I Need and Accessible Parking Placard”, a column by Jennifer Powell.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/